Vaginal microbiota and urinary tract infections in women: the protective role of vaginal lactobacilli in counteracting urinary tract infections occurrence and recurrence
Open accessThe DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index; 50 of the 114 sources its claims cite were checked for support.
Abstract
Urinary Tract Infections (UTIs) are common clinical conditions.Women are affected by UTIs more than men and their probability of experiencing such conditions is high (60%).The vagina and its defensive system play a key role in the pathogenesis of UTIs, making the vaginal microbiota (VMB) a target for controlling UTIs and their recurrence (rUTIs).Current therapy consists of low-dose antibiotics for rUTIs prevention.The increasing incidence of antimicrobial resistance documented to date has rendered this strategy less attractive.The initial step of UTIs pathogenesis involves colonization of the vaginal introitus and periurethra by uropathogens.The following steps may include the ascension of uropathogens via the urethra to the bladder and kidneys.Vaginal infections may be caused by uropathogens from the intestinal microbiota, taking advantage of the proximity between the anus and the vagina.Nevertheless, uropathogens may arise from the vagina itself because of alterations in VMB.Changes in VMB lead to Bacterial Vaginosis (BV), which consists of the replacement of healthy lactobacilli with unhealthy Gram-negative bacteria, such as Escherichia coli.The documented relationship between BV and UTIs supports the intriguing hypothesis that restoring VMB may represent a new option to control UTIs and rUTIs after short-term antibiotic treatment in a safe and costeffective manner.
Overview
CoChat Summary
## TL;DR
This is a narrative review arguing that vaginal microbiota, especially lactobacilli, play a protective role in women’s urinary tract infections (UTIs) and that restoring a lactobacilli-dominated vaginal ecosystem may help prevent recurrence. It does not report new patient data; instead, it synthesizes prior literature and highlights topical probiotic/symbiotic approaches as promising adjuncts to antibiotics.
## Key findings
- The paper states that women have a high lifetime probability of UTIs, reported here as 60%, and that recurrence is defined as 3 or more episodes in 1 year or more than 2 in 6 months.
- It reports that approximately 25% of women with a first UTI develop a second episode, and 25% of those go on to have a third and further recurrence.
- It notes that E. coli is responsible for 85% of community-acquired UTIs and about 50% of hospital-acquired instances, and that increasing antibiotic resistance is making standard treatment less effective.
- The review cites clinical studies in which vaginal lactobacilli were associated with reduced recurrences, including a trial of 174 women in which vaginal probiotics with or without oral probiotics outperformed oral probiotics alone, and a study where L. crispatus reduced recurrent cystitis in 86% of patients, with the suppressive effect persisting in 77% for at least a year after therapy ended.
- It also states that a symbiotic approach using Lactobacillus rhamnosus BMX 54 + lactose had been validated in more than 3000 women with vaginitis/BV and showed statistically significant effectiveness in reducing recurrences.
## Methods
- Design: Narrative review.
- Data/sample: Non-systematic literature search in PubMed using keywords related to UTIs, vaginal microbiota, Lactobacillus spp., bacterial vaginosis, and probiotics; English-language articles from 1994 to 2025 were considered, with additional references taken from bibliographies.
- Analysis: Qualitative synthesis of prior clinical and mechanistic studies; no meta-analysis, no original statistical analysis, and no new patient cohort are reported.
## Limitations
- The paper explicitly states that the literature it reviews is heterogeneous in study design, methodology, randomization, number of enrolled patients, treatment schedules, and definitions of recurrence.
- It explicitly says that more specific double-blind randomized controlled studies are required to confirm the conclusions.
- Evident from the text: because this is a non-systematic narrative review, the conclusions depend on selected prior studies and are not based on a systematic evidence synthesis.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
38 Valid · 2 Not valid · 20 Not checked · 6 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Several recent clinical studies have demonstrated that topical Lactobacillus therapy as 'complementary treatment' after antibiotic therapy, especially with vaginal suppositories, can significantly reduce the frequency of rUTIs, even in postmenopausal women with refractory infections [6, 14-16], highlighting the therapeutic potential of microbiome-targeted strategies.”
What the sources say
- Partly supportedcites [6] [6] Sekito T, Wada K, Ishii A, et al. Etiology of recurrent cystitis in postmenopausal women based on vaginal microbiota and the role of Lactobacillus vaginal suppository. Front Microbiol. 2023; 14: 1-9. sourceExperimental — accuracy not yet measured
Split into 2 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
- Not checked — no full text of the sourcecites [14] [14] Stapleton AE, Au-Yeung M, Hooton TM, et al. Randomized, Placebo-Controlled Phase 2 Trial of a Lactobacillus crispatus Probiotic Given Intravaginally for Prevention of Recurrent Urinary Tract Infection. Clin Infect Dis. 2011; 52(10): 1212-1217. source
- Partly supportedcites [15] [15] Mastromarino P, Macchia S, Meggiorini L, et al. Effectiveness of Lactobacillus-containing vaginal tablets in the treatment of symptomatic bacterial vaginosis. Clin Microbiol Infect. 2009; 15: 67-74. sourceExperimental — accuracy not yet measured
The Discussion reports that vaginal Lactobacillus tablets helped treat recurrent bacterial vaginosis and suggests their use after systemic antibiotics; it does not report a reduction in recurrent urinary tract infections. The Patients section specifies premenopausal women and excludes recent antibiotic use, so the claimed result in postmenopausal women with refractory infections is not supported. (LLM, conf=0.88)
- Not matchedcites [16] [16] Ebell MH. Probiotics Reduce the Likelihood of Recurrence of UTI in Women with Frequent UTIs. Am Fam Physician. 2025; 111(1): 84-85.
We searched by its title and found no matching paper.
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“These shifts support evidence that dysbiosis - whether induced by antibiotics, hormonal changes, or behavioral factors - can compromise mucosal defenses and promote pathogen colonization [2, 6].”
What the sources say
- Not matchedcites [2] [2] Stapleton AE. The Vaginal Microbiota and Urinary Tract Infection. Microbiol Spectr. 2016; 4(6): 1-9.
We searched by its title and found no matching paper.
- Partly supportedcites [6] [6] Sekito T, Wada K, Ishii A, et al. Etiology of recurrent cystitis in postmenopausal women based on vaginal microbiota and the role of Lactobacillus vaginal suppository. Front Microbiol. 2023; 14: 1-9. sourceExperimental — accuracy not yet measured
The Introduction (page unavailable) reports changes in vaginal microbiota in postmenopausal women, and the Discussion (page unavailable) says repeated antibiotic exposure may cause dysbiosis. The Discussion also describes how Lactobacillus inhibits vaginal uropathogen colonization, supporting the proposed protective role of the microbiota. The paper does not address behavioral factors as a cause of dysbiosis or directly establish that dysbiosis compromises mucosal defenses. (LLM, conf=0.85)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Not matched
Every source the paper cites for this claim was checked and supports it.
In the paper
“Recurrences are more common in women than in men because of risk factors such as sexual intercourse, urogenital aging, pelvic organ prolapse, urethral diverticula, vesicovaginal fistula, urinary incontinence, menopause, and pregnancy [5].”
What the sources say
- Supportedcites [5] [5] Kim A, Ahn J, Choi WS, et al. What is the Cause of Recurrent Urinary Tract Infection? Contemporary Microscopic Concepts of Pathophysiology. Int Neurourol. J. 2021; 25(3): 192-201. source
The Introduction states that women are much more likely than men to have recurrent UTIs and gives the same list of risk factors. The citing sentence closely paraphrases that passage. (LLM, conf=0.95)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Antibiotic resistance in UTIs is increasing owing to two major factors: the worldwide spread of such infections and the widespread use of antibiotics as the gold standard therapy for UTIs [17].”
What the sources say
- Partly supportedcites [17] [17] Timm MR, Russell S, Hultgren SJ. Urinary tract infections: pathogenesis, host susceptibility and emerging therapeutics. Nat Rev Microbiol. 2025; 23(2): 72-86. sourceExperimental — accuracy not yet measured
The Introduction says antibiotic resistance in UTIs is rising, and the Abstract says the large quantity of antibiotics prescribed for UTIs contributes to resistant pathogens. The Introduction also describes UTIs as a global health problem, but the paper does not identify the worldwide spread of infections as a cause of rising resistance. Page numbers were not provided in our copy. (LLM, conf=0.88)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Several Lactobacillus species, such as L. crispatus , L. jensenii , L. gasseri , and L. iners , constitute most of the vaginal microbiota in women of reproductive age [1, 30, 31].”
What the sources say
- Supportedcites [1] [1] Lewis AL, Gilbert NM. Roles of the vagina and the vaginal microbiota in urinary tract infection: evidence from clinical correlations and experimental models. GMS Infect Dis . 2020; 8: 1-10. source
Section 3.1 'Vaginal microbiota composition' (p. 1) states verbatim that in reproductive age women the vaginal microbiota is dominated by a few Lactobacillus species, naming L. crispatus, L. gasseri, L. jensenii and L. iners — the same four taxa and the same population the claim attributes to this source. The surrounding passage qualifies this by noting up to one-third of US women lack Lactobacillus dominance, but that does not contradict the claim's 'constitute most of the vaginal microbiota' framing for reproductive age women generally. (LLM, conf=0.93)
- Not checked — no full text of the sourcecites [30] [30] Borges S, Silva J, Teixeira P. The role of lactobacilli and probiotics in maintaining vaginal health. Arch Gynecol Obstet. 2014; 289(3): 479-89. source
- Supportedcites [31] [31] Tachedjian G, Aldunate M, Bradshaw CS, et al. The role of lactic acid production by probiotic Lactobacillus species in vaginal health. Res Microbiol. 2017; 168: 782-792. source
Section 2, “Vaginal eubiosis and dysbiosis,” states that the vaginal microbiota in reproductive-age women during eubiosis is typically dominated by the four named Lactobacillus species. This supports the cited sentence’s description of typical Lactobacillus-dominated microbiota, rather than implying that every woman has such a microbiota. (LLM, conf=0.94)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
24 more claims · 14 with their cited sources checked
Create a free account to see all 66 claims and to verify the 2 references still open.
- Probably not a substantial claim. 18
- It may state two separate claims as one. 24
Citations
Cites
The publisher hasn’t deposited this paper’s reference list.
Research works printed but not linked: 18
- [2][2] Stapleton AE. The Vaginal Microbiota and Urinary Tract Infection. Microbiol Spectr. 2016; 4(6): 1-9.
- [4][4] Albert X, Huertas I, Pereiro I, et al. Antibiotics for preventing recurrent urinary tract infection in nonpregnant women (Review). Cochrane Database of Systematic Reviews. 2004; 3: CD001209.
- [7][7] Mare ş C, Petca RC, Popescu RI, et al. Update on Urinary Tract Infection Antibiotic Resistance - A Retrospective Study in Females in Conjunction with Clinical Data. Life. 2024; 14: 106.
- [10][10] Meštrovi ć T, Matijaši ć M, Peri ć M, et al. The Role of Gut, Vaginal, and Urinary Microbiome in Urinary Tract Infections: From Bench to Bedside. Diagnostics. 2021; 11: 7.
- [16][16] Ebell MH. Probiotics Reduce the Likelihood of Recurrence of UTI in Women with Frequent UTIs. Am Fam Physician. 2025; 111(1): 84-85.
- [19][19] Pires C. A Systematic Review of Controlled Trials: Can Patient Adherence to Antibiotics Be Improved Through Pharmaceutical Communication-Based Interventions? Pharmacy . 2024; 12: 178.
- [20][20] Ghosh R. A Study on the Prevalence of E. coli in the Urinary Tract Infection and the Risk Factors Associated with It. Clinical Microbiology. 2024; 13(3): 1-8.
- [21][21] Peralta C, Cortiñas AC, Culaway JM, et al. A Systematic Review on Escherichia coli in Urinary Tract Infections: Prevalence, Resistance Patterns, and Virulence Factors. Int J Innovative Sci Res T ech. 2024; 9(11): 2300-2308.
- [24][24] He Y, Zhao J, Wang L, et al. Epidemiological trends and predictions of urinary tract infections in the global burden of disease study 2021. Sci Report. 2025; 15: 4702.
- [32][32] Hudson PL, Hung KJ, Bergerat A, et al. Effect of Vaginal Lactobacillus Species on Escherichiacoli Growth. Female Pelvic Med Reconstr Surg. 2020; 26(2): 146-151.
- [48][48] Stojanovi ć N, Ple ć aš D, Plešinac S. Normal vaginal flora disorders and application of probiotics in pregnancy. Arch Gynecol Obstet. 2012; 286(2): 325-332.
- [49][49] Rossi A, Cattadori F, Corti B. The vaginal ecosystem: how to protect and maintain it. J Obst Prac Gynecol Perinatal Med . 2003; 18: 1.
- [52][52] Recine N, Musciola A, Moreira E. The benefits of topical vaginal therapy with Lactobacillus casei subrhamnosus in preventing bacterial vaginosis relapses. Communications and Posters for the X National IBAT Conference 2011, Naples, Italy - January 26-28. 18 (Suppl. 1).
- [59][59] Luzi G, Iazzetta E, Cecconi L, et al. Lactobacillus rhamnosus BMX 54 Vaginal application usefulness as adjuvant therapy for Preterm Premature Rupture of Membranes (PPROM) in the second Trimester of Pregnancy. Int J Ped Neonatal Health. 2018; 2(1): 14-20.
- [61][61] De Punzio C, Bertini M, Senesi S. Open label pilot study of lactobacillus casei sub-rhamnosus in treating aspecific vaginal diseases. Proceedings from the Italian Society of Gynecology and Obstetrics , Viareggio, 20-24 June, 1999.
- [64][64] Bertini M. Is time for thinking to vaginal microbiome to prevent sexually transmitted diseases? Int J Fam Commun Med. 2018; 2: 1.
- [65][65] Bertini M. Bacterial vaginosis and sexually transmitted diseases: relationship and management. In: Serdaroglu, S., Kutlubay, Z., editors. Fundamentals of Sexually Transmitted Infections. INTECH Open ; 2017: 75.
- [66][66] Friedrich EGJr. Vaginitis. Am J Obstet Gynecol , 1985; 152(3): 247-251.
Cited by
More than an infection: the ecological puzzle of recurrent urinary tract infections
Musleh, L., Montilli, M., Ammendolia, M. G., Sciarra, A., Riccioli, A., Maurizi, L., & Longhi, C. (2026) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2026.1927507 · Cited by 1
“In postmenopausal women, topical vaginal estrogen supports epithelial integrity and promotes Lactobacillus recovery, reducing recurrence risk (Moriconi et al., 2026).”
Metadata
- Authors
- Moriconi, F., Pelagagge, M., & Bertini, M.
- Affiliations
- Baldacci (Italy) (IT)
- Venue
- infezioni in medicina
- Published
- 2026-03-01
- Volume
- 34
- Issue
- 1
- Pages
- 39-48
- ISSN
- 1124-9390 (ISSN-L)
- 2532-8689
- PMC
- PMC12959630
- OpenAlex
- W7134074016
- Semantic Scholar
- a96654371d928b3be4c673d53216b4310ae7fb6e
- Cited by
- 1
- References
- 0
- Citations by year
- 2026: 1
- FWCI
- 1.15
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Infezioni in Medicina (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (publishedVersion)
- Topics
- Health Sciences › Medicine › Urology › Urinary Tract Infections Management
- Life Sciences › Immunology and Microbiology › Microbiology › Reproductive tract infections research
- Health Sciences › Medicine › Urology › Urinary Bladder and Prostate Research
- Keywords
- vaginal microbiota, urinary tract infection, recurrent urinary tract infection, vaginal lactobacilli, bacterial vaginosis, Escherichia coli, uropathogens, antimicrobial resistance, women, vaginal microbiota restoration
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol and qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Vaginal microbiota and urinary tract infections in women: the protective role of vaginal lactobacilli in counteracting urinary tract infections occurrence and recurrence. https://app.cochat.ai/papers/10.53854/liim-3401-4
- The paper
- Moriconi, F., Pelagagge, M., & Bertini, M. (2026). Vaginal microbiota and urinary tract infections in women: the protective role of vaginal lactobacilli in counteracting urinary tract infections occurrence and recurrence. infezioni in medicina. https://doi.org/10.53854/liim-3401-4
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.

![Figure 2 Diagnosis and Management of the common Vaginitis [66].](https://figures.cochat.ai/paper-figures/ee59cec02135430a9ce72b3739be23ae/vaginal-microbiota-and-urinary-tract-infections-in-women-the-protective-role-of-figure-2.png)

